Estimation of Improvements in Mortality in Spectrum Among Adults With HIV Receiving Antiretroviral Therapy in High-Income Countries.
Adam TrickeyRobert GlaubiusNikos PantazisRobert ZangerleLinda WittkopJanne VehreschildSophie GrabarMatthias CavassiniRamon TeiraAntonella d'Arminio MonforteJordi CasabonaArd van SighemInma JarrinSuzanne M IngleJonathan A C SterneJeffrey W Imai-EatonLeigh F JohnsonPublished in: Journal of acquired immune deficiency syndromes (1999) (2024)
Spectrum's all-cause mortality estimates among PLHIV are consistent with age/country-controlled mortality observed in ART-CC, with some underestimation of mortality among women. Comparing results suggest that 60%-70% of excess deaths among PLHIV on ART in Spectrum are from non-AIDS causes.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv infected patients
- hiv aids
- cardiovascular events
- risk factors
- pregnant women
- cardiovascular disease
- physical activity
- polycystic ovary syndrome
- metabolic syndrome
- hepatitis c virus
- insulin resistance
- adipose tissue
- skeletal muscle
- pregnancy outcomes
- men who have sex with men